Sotera Health Future Growth
Future criteria checks 5/6
Sotera Health is forecast to grow earnings and revenue by 38.3% and 5.9% per annum respectively. EPS is expected to grow by 37.7% per annum. Return on equity is forecast to be 37.6% in 3 years.
Key information
38.3%
Earnings growth rate
37.7%
EPS growth rate
Life Sciences earnings growth | 22.5% |
Revenue growth rate | 5.9% |
Future return on equity | 37.6% |
Analyst coverage | Good |
Last updated | 05 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,263 | 173 | 301 | N/A | 3 |
12/31/2025 | 1,178 | 138 | 278 | 312 | 7 |
12/31/2024 | 1,103 | 93 | 207 | 254 | 7 |
3/31/2024 | 1,077 | 55 | -377 | -172 | N/A |
12/31/2023 | 1,049 | 51 | -363 | -148 | N/A |
9/30/2023 | 991 | -306 | -381 | -159 | N/A |
6/30/2023 | 976 | -268 | -342 | -133 | N/A |
3/31/2023 | 988 | -261 | 70 | 262 | N/A |
12/31/2022 | 1,004 | -234 | 96 | 278 | N/A |
9/30/2022 | 993 | 121 | 90 | 242 | N/A |
6/30/2022 | 971 | 123 | 127 | 256 | N/A |
3/31/2022 | 956 | 135 | 159 | 275 | N/A |
12/31/2021 | 931 | 115 | 179 | 282 | N/A |
9/30/2021 | 907 | 36 | 156 | 237 | N/A |
6/30/2021 | 881 | 9 | 127 | 202 | N/A |
3/31/2021 | 842 | -26 | 110 | 171 | N/A |
12/31/2020 | 818 | -39 | 67 | 121 | N/A |
9/30/2020 | 795 | -23 | 55 | 109 | N/A |
6/30/2020 | 790 | -28 | 68 | 124 | N/A |
3/31/2020 | 772 | -29 | 58 | 116 | N/A |
12/31/2019 | 778 | -21 | 92 | 149 | N/A |
12/31/2018 | 746 | -6 | 47 | 120 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SH5's forecast earnings growth (38.3% per year) is above the savings rate (0.7%).
Earnings vs Market: SH5's earnings (38.3% per year) are forecast to grow faster than the German market (18.8% per year).
High Growth Earnings: SH5's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SH5's revenue (5.9% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: SH5's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SH5's Return on Equity is forecast to be high in 3 years time (37.6%)